Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

OBJECTIVE: This multicenter, open-label, parallel-arm study compared the efficacy and safety of exenatide once weekly (EQW) with titrated insulin detemir in patients with type 2 diabetes inadequately controlled with metformin (with or without sulfonylureas). RESEARCH DESIGN AND METHODS: Patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Melanie, Heller, Simon, Sreenan, Seamus, Sapin, Hélène, Adetunji, Omolara, Tahbaz, Arash, Vora, Jiten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631870/
https://www.ncbi.nlm.nih.gov/pubmed/23275363
http://dx.doi.org/10.2337/dc12-1333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631870/
https://www.ncbi.nlm.nih.gov/pubmed/23275363
http://dx.doi.org/10.2337/dc12-1333

Ejemplares similares